ReviewJournal of imaging informatics in medicine2026
Deep Learning Segmentation of Abdominal Organs Across Ultrasound, MRI, and CT: A Scoping Review of Modality-Specific Approaches and the Emerging Role of Foundation Models and LLM-Based Agents.
Review in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Segmentation of the liver, kidneys, and pancreas underpins volumetry, treatment planning, and disease monitoring across ultrasound (US), magnetic resonance imaging (MRI), and computed tomography (CT). Deep learning has advanced through four waves-convolutional networks, transformers, segmentation foundation models, and large language model (LLM)-based agents-but how performance differs across organs and modalities has not been synthesized in a segmentation-centric, modality-stratified way. Following scoping-review reporting guidance, we searched five databases for studies published 2020-2026 and charted 72 studies by organ, modality, method family, dataset, and performance. Organ tractability was consistent (liver > kidney > > pancreas), as was modality maturity (CT > MRI > US), with one benchmark-driven exception for the pancreas; tumor segmentation lagged organ segmentation throughout. Foundation models matched or exceeded equally box-prompted specialists on individual unseen tasks, but the most frequently cited result of this kind belongs to the Segment Anything Model (SAM) rather than to a medically adapted model, and every comparator in it received the same ground-truth-derived box. On the two benchmarks in our pool containing a fully automatic comparator, that comparator led on one and was within about one Dice point on the other, and no benchmark evaluated specialists, foundation models, and agents under a single common protocol. Performance degraded sharply on the pancreas and on ultrasound. LLM/agentic methods did not surpass specialists on overlap metrics, offering gains instead in generality, autonomy, and annotation efficiency. This modality-stratified synthesis shows where ultrasound and the pancreas remain underserved, and indicates that agentic approaches currently augment rather than replace specialist segmentation.
Indexed as
Identifiers
42722950What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.